Multiply Labs
| Private | |
| ISIN | 🆔 |
| Industry |
|
| Founded 📆 | 2016 |
| Founders 👔 |
|
| Headquarters 🏙️ | , San Francisco, California , United States |
Area served 🗺️ | |
Key people | Fred Parietti (CEO) |
| Products 📟 | Robotic pharmaceutical manufacturing systems |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Multiply Labs is an American company that develops robotic systems for automated pharmaceutical manufacturing, with a focus on cell therapy production. Founded in 2016 and headquartered in San Francisco, the company builds robotic systems intended to automate manufacturing steps that are traditionally performed manually.[1][2]
History
Multiply Labs was founded in 2016 by Fred Parietti and Alice Melocchi. The company initially developed robotic systems to produce personalized capsules for clinical trials before expanding into cell therapy manufacturing.[1] In April 2021, it raised a $20 million Series A round led by Casdin Capital, with participation from Lux Capital and Founders Fund's Pathfinder vehicle.[1]
Technology
The company's systems use collaborative robots to automate manufacturing steps traditionally carried out by hand, and are designed to operate with instruments already used in existing cell therapy workflows.[2] According to the company, automation can substantially reduce per-dose manufacturing costs and increase output relative to manual production.[3]
Collaborations
Multiply Labs has entered agreements with several cell therapy developers to evaluate robotic automation of their manufacturing. In 2024 it announced a collaboration with Legend Biotech, which received priority access to its systems.[3] In 2026 it announced a collaboration with AstraZeneca to evaluate manufacturing-ready robotic systems for commercial-scale cell therapy production.[4]
Operations
In May 2026, Multiply Labs established an Italian subsidiary, Multiply Labs Italia, in Turin, appointing Enrico Racca as its founding general manager.[5]
References
- ↑ 1.0 1.1 1.2 Crowe, Steve (April 14, 2021). "Multiply Labs raises $20M for robotic pharma manufacturing". The Robot Report. Retrieved July 1, 2026.
- ↑ 2.0 2.1 Gibney, Michael (May 29, 2024). "Can robots break the cell therapy bottleneck?". BioPharma Dive. Retrieved July 1, 2026.
- ↑ 3.0 3.1 Kansteiner, Fraiser (September 24, 2024). "Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy production tech". Fierce Pharma. Retrieved July 1, 2026.
- ↑ "Multiply Labs partners with AstraZeneca to automate cell therapy manufacturing". The Robot Report. 2026. Retrieved July 1, 2026.
- ↑ "Enrico Racca joins Multiply Labs" (Press release). Multiply Labs. May 27, 2026. Retrieved July 1, 2026.
Category:Companies based in San Francisco Category:Biotechnology companies of the United States Category:Robotics companies of the United States Category:Manufacturing companies established in 2016 Category:2016 establishments in California
This article "Multiply Labs" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Multiply Labs. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
